Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents01:29

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel Disease...
Immunodeficiency Diseases01:25

Immunodeficiency Diseases

Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency disorders...
Cell-mediated Immune Responses01:40

Cell-mediated Immune Responses

Overview
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Exercise frequency and physician burnout among colorectal surgeons in the USA: should we be worried?

Techniques in coloproctology·2026
Same author

Bulk Spin-Orbit Torque-Driven Spin Hall Nano-Oscillators Using PtBi Alloys with Engineered Crystallinity.

ACS applied materials & interfaces·2026
Same author

Curative-intent stereotactic ablative body radiation, surgery, and systemic therapy in non-osseous oligometastatic breast cancer.

Breast cancer research and treatment·2026
Same author

Nanosecond phase ordering in ultra-large spin Hall nano-oscillator lattices for unconventional computing.

Nature nanotechnology·2026
Same author

PFAS in the circular economy: An unintended consequence of recycling and wastewater reuse?

Integrated environmental assessment and management·2026
Same author

A review on assessment of advances in polymers and their hybrid nanosystem for leukaemia theranostics applications.

Biomedical materials (Bristol, England)·2026

Related Experiment Video

Updated: May 25, 2026

Induction of Alloantigen-specific Anergy in Human Peripheral Blood Mononuclear Cells by Alloantigen Stimulation with Co-stimulatory Signal Blockade
11:55

Induction of Alloantigen-specific Anergy in Human Peripheral Blood Mononuclear Cells by Alloantigen Stimulation with Co-stimulatory Signal Blockade

Published on: March 14, 2011

Immunosuppressive therapy in aplastic anemia.

Vineeta Gupta1, Akash Kumar, Vijai Tilak

  • 1Department of Pediatrics, Institute of Medical Sciences, Banaras Hindu University, Varanasi, 221005, India. vineetaguptabhu@gmail.com

Indian Journal of Pediatrics
|January 26, 2012
PubMed
Summary

Antithymocyte globulin based immunosuppressive therapy (IST) shows a one-third overall response rate in pediatric aplastic anemia patients. This treatment is challenging but offers hope for complete and partial recovery.

More Related Videos

In Vitro and In Vivo Assessment of T, B and Myeloid Cells Suppressive Activity and Humoral Responses from Transplant Recipients
18:48

In Vitro and In Vivo Assessment of T, B and Myeloid Cells Suppressive Activity and Humoral Responses from Transplant Recipients

Published on: August 12, 2017

Killer Artificial Antigen Presenting Cells (KaAPC) for Efficient In Vitro Depletion of Human Antigen-specific T Cells
08:12

Killer Artificial Antigen Presenting Cells (KaAPC) for Efficient In Vitro Depletion of Human Antigen-specific T Cells

Published on: August 11, 2014

Related Experiment Videos

Last Updated: May 25, 2026

Induction of Alloantigen-specific Anergy in Human Peripheral Blood Mononuclear Cells by Alloantigen Stimulation with Co-stimulatory Signal Blockade
11:55

Induction of Alloantigen-specific Anergy in Human Peripheral Blood Mononuclear Cells by Alloantigen Stimulation with Co-stimulatory Signal Blockade

Published on: March 14, 2011

In Vitro and In Vivo Assessment of T, B and Myeloid Cells Suppressive Activity and Humoral Responses from Transplant Recipients
18:48

In Vitro and In Vivo Assessment of T, B and Myeloid Cells Suppressive Activity and Humoral Responses from Transplant Recipients

Published on: August 12, 2017

Killer Artificial Antigen Presenting Cells (KaAPC) for Efficient In Vitro Depletion of Human Antigen-specific T Cells
08:12

Killer Artificial Antigen Presenting Cells (KaAPC) for Efficient In Vitro Depletion of Human Antigen-specific T Cells

Published on: August 11, 2014

Area of Science:

  • Hematology
  • Pediatric Oncology
  • Immunosuppressive Therapy

Background:

  • Idiopathic aplastic anemia (AA) in children presents a significant therapeutic challenge.
  • Standard treatments aim to restore hematopoiesis and improve survival rates.

Purpose of the Study:

  • To evaluate the efficacy of antithymocyte globulin (ATG) based immunosuppressive therapy (IST) in pediatric patients diagnosed with idiopathic aplastic anemia.
  • To assess treatment response rates, including complete response (CR) and partial response (PR), and identify factors influencing outcomes.

Main Methods:

  • A cohort of 30 pediatric patients with idiopathic aplastic anemia (22 severe, 8 very severe) received ATG and cyclosporine.
  • Patient response was assessed at 3 months, 6 months, and 1 year post-therapy.

Main Results:

  • An overall response rate of 33.3% was observed by 6 months, with 29.7% responding at 3 months (3 CR, 5 PR).
  • Responders demonstrated a shorter duration of illness and higher absolute neutrophil counts compared to non-responders.
  • No patients developed acute leukemia during the follow-up period.

Conclusions:

  • ATG-based IST is a viable treatment option for pediatric aplastic anemia, achieving meaningful response rates in approximately one-third of patients.
  • Early intervention and specific clinical parameters may predict treatment success.